Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Medicine for Osteoarthritis Pain Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Medicine for Osteoarthritis Pain Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Injection
      • 1.3.4 External
    • 1.4 Market Segment by Application
      • 1.4.1 Global Medicine for Osteoarthritis Pain Market Share by Application (2019-2025)
      • 1.4.2 Medical Care
      • 1.4.3 Personal Care
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Medicine for Osteoarthritis Pain Market Size
      • 2.1.1 Global Medicine for Osteoarthritis Pain Revenue 2014-2025
      • 2.1.2 Global Medicine for Osteoarthritis Pain Sales 2014-2025
    • 2.2 Medicine for Osteoarthritis Pain Growth Rate by Regions
      • 2.2.1 Global Medicine for Osteoarthritis Pain Sales by Regions 2014-2019
      • 2.2.2 Global Medicine for Osteoarthritis Pain Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Medicine for Osteoarthritis Pain Sales by Manufacturers
      • 3.1.1 Medicine for Osteoarthritis Pain Sales by Manufacturers 2014-2019
      • 3.1.2 Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Medicine for Osteoarthritis Pain Revenue by Manufacturers (2014-2019)
      • 3.2.2 Medicine for Osteoarthritis Pain Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Medicine for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
    • 3.3 Medicine for Osteoarthritis Pain Price by Manufacturers
    • 3.4 Key Manufacturers Medicine for Osteoarthritis Pain Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Medicine for Osteoarthritis Pain Market
    • 3.6 Key Manufacturers Medicine for Osteoarthritis Pain Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Sales and Revenue (2014-2019)
      • 4.1.2 Injection Sales and Revenue (2014-2019)
      • 4.1.3 External Sales and Revenue (2014-2019)
    • 4.2 Global Medicine for Osteoarthritis Pain Sales Market Share by Type
    • 4.3 Global Medicine for Osteoarthritis Pain Revenue Market Share by Type
    • 4.4 Medicine for Osteoarthritis Pain Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Medicine for Osteoarthritis Pain Sales by Application

    6 United States

    • 6.1 United States Medicine for Osteoarthritis Pain Breakdown Data by Company
    • 6.2 United States Medicine for Osteoarthritis Pain Breakdown Data by Type
    • 6.3 United States Medicine for Osteoarthritis Pain Breakdown Data by Application

    7 European Union

    • 7.1 European Union Medicine for Osteoarthritis Pain Breakdown Data by Company
    • 7.2 European Union Medicine for Osteoarthritis Pain Breakdown Data by Type
    • 7.3 European Union Medicine for Osteoarthritis Pain Breakdown Data by Application

    8 China

    • 8.1 China Medicine for Osteoarthritis Pain Breakdown Data by Company
    • 8.2 China Medicine for Osteoarthritis Pain Breakdown Data by Type
    • 8.3 China Medicine for Osteoarthritis Pain Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Medicine for Osteoarthritis Pain Breakdown Data by Company
    • 9.2 Rest of World Medicine for Osteoarthritis Pain Breakdown Data by Type
    • 9.3 Rest of World Medicine for Osteoarthritis Pain Breakdown Data by Application
    • 9.4 Rest of World Medicine for Osteoarthritis Pain Breakdown Data by Countries
      • 9.4.1 Rest of World Medicine for Osteoarthritis Pain Sales by Countries
      • 9.4.2 Rest of World Medicine for Osteoarthritis Pain Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.1.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Johnson & Johnson
      • 10.2.1 Johnson & Johnson Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.2.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.2.5 Johnson & Johnson Recent Development
    • 10.3 GlaxoSmithKline
      • 10.3.1 GlaxoSmithKline Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.3.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.3.5 GlaxoSmithKline Recent Development
    • 10.4 Bayer
      • 10.4.1 Bayer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.4.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.4.5 Bayer Recent Development
    • 10.5 Eli Lilly
      • 10.5.1 Eli Lilly Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.5.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.5.5 Eli Lilly Recent Development
    • 10.6 Novartis
      • 10.6.1 Novartis Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.6.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.6.5 Novartis Recent Development
    • 10.7 Sanofi
      • 10.7.1 Sanofi Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.7.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.7.5 Sanofi Recent Development
    • 10.8 Horizon Pharma
      • 10.8.1 Horizon Pharma Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.8.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.8.5 Horizon Pharma Recent Development
    • 10.9 Abbott
      • 10.9.1 Abbott Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.9.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.9.5 Abbott Recent Development
    • 10.10 Mylan
      • 10.10.1 Mylan Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
      • 10.10.4 Medicine for Osteoarthritis Pain Product Introduction
      • 10.10.5 Mylan Recent Development
    • 10.11 Daiichi Sankyo
    • 10.12 TEVA
    • 10.13 Almatica Pharma
    • 10.14 Astellas Pharma
    • 10.15 Tide Pharmaceutical
    • 10.16 Iroko Pharmaceuticals
    • 10.17 Hengrui Pharmaceutical
    • 10.18 Abiogen Pharma

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Medicine for Osteoarthritis Pain Sales Channels
      • 11.2.2 Medicine for Osteoarthritis Pain Distributors
    • 11.3 Medicine for Osteoarthritis Pain Customers

    12 Market Forecast

    • 12.1 Global Medicine for Osteoarthritis Pain Sales and Revenue Forecast 2019-2025
    • 12.2 Global Medicine for Osteoarthritis Pain Sales Forecast by Type
    • 12.3 Global Medicine for Osteoarthritis Pain Sales Forecast by Application
    • 12.4 Medicine for Osteoarthritis Pain Forecast by Regions
      • 12.4.1 Global Medicine for Osteoarthritis Pain Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Medicine for Osteoarthritis Pain Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Medicine for Osteoarthritis Pain is to relieve pain, and cannot slow the progress of osteoarthritis.
      In 2019, the market size of Medicine for Osteoarthritis Pain is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 5.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Medicine for Osteoarthritis Pain.

      This report studies the global market size of Medicine for Osteoarthritis Pain, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Medicine for Osteoarthritis Pain sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Johnson & Johnson
      GlaxoSmithKline
      Bayer
      Eli Lilly
      Novartis
      Sanofi
      Horizon Pharma
      Abbott
      Mylan
      Daiichi Sankyo
      TEVA
      Almatica Pharma
      Astellas Pharma
      Tide Pharmaceutical
      Iroko Pharmaceuticals
      Hengrui Pharmaceutical
      Abiogen Pharma

      Market Segment by Product Type
      Oral
      Injection
      External

      Market Segment by Application
      Medical Care
      Personal Care

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Medicine for Osteoarthritis Pain status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Medicine for Osteoarthritis Pain manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Medicine for Osteoarthritis Pain are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now